Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Mutation Research
|
May 10, 2001
Mitochondrial DNA in human malignancy
J S Penta, F M Johnson, J T Wachsman, et al.
American Journal of Clinical Oncology
|
February 1, 1982
Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma
D S Poster, S Bruno, J S Penta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1981
Selected anticancer drugs in Phase I trials in the United States (1979--1980)
F M Muggia, J S Penta, R Catane, et al.
European Journal of Cancer
|
November 1, 1977
ICRF-159: current status and clinical prospects
R E Bellet, M Rozencweig, D D Von Hoff, et al.
Cancer Treatment Reports
|
August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents
D D Von Hoff, M Rozencweig, W T Soper, et al.
Cancer Research
|
June 1, 1979
Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents
A M Guarino, M Rozencweig, I Kline, et al.
The British Journal of Cancer. Supplement
|
June 1, 1978
The hypoxic cell sensitizer programme in the United States
T L Phillips, T H Wasserman, JohnsonRJ, et al.
Cancer Clinical Trials
|
January 1, 1981
Animal toxicology for early clinical trials with anticancer agents
M Rozencweig, D D Von Hoff, M J Staquet, et al.
Cancer Research
|
February 1, 1992
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
P C Adamson, F M Balis, J Miser, et al.
Cancer Research
|
August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule
P C Adamson, F M Balis, J Miser, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Mutation Research
|
May 10, 2001
Mitochondrial DNA in human malignancy
J S Penta, F M Johnson, J T Wachsman, et al.
American Journal of Clinical Oncology
|
February 1, 1982
Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma
D S Poster, S Bruno, J S Penta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1981
Selected anticancer drugs in Phase I trials in the United States (1979--1980)
F M Muggia, J S Penta, R Catane, et al.
European Journal of Cancer
|
November 1, 1977
ICRF-159: current status and clinical prospects
R E Bellet, M Rozencweig, D D Von Hoff, et al.
Cancer Treatment Reports
|
August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents
D D Von Hoff, M Rozencweig, W T Soper, et al.
Cancer Research
|
June 1, 1979
Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents
A M Guarino, M Rozencweig, I Kline, et al.
The British Journal of Cancer. Supplement
|
June 1, 1978
The hypoxic cell sensitizer programme in the United States
T L Phillips, T H Wasserman, JohnsonRJ, et al.
Cancer Clinical Trials
|
January 1, 1981
Animal toxicology for early clinical trials with anticancer agents
M Rozencweig, D D Von Hoff, M J Staquet, et al.
Cancer Research
|
February 1, 1992
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
P C Adamson, F M Balis, J Miser, et al.
Cancer Research
|
August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule
P C Adamson, F M Balis, J Miser, et al.
Page
of 2